675
Views
3
CrossRef citations to date
0
Altmetric
Letters to the Editor

Extended survival after chemotherapy and conservative radiotherapy for HPV-16 positive stage IVB oropharyngeal carcinoma

, , &
Pages 1236-1237 | Received 15 Jan 2013, Accepted 24 Jan 2013, Published online: 19 Feb 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Ralph T. H. Leijenaar, Sara Carvalho, Frank J. P. Hoebers, Hugo J. W. L. Aerts, Wouter J. C. van Elmpt, Shao Hui Huang, Biu Chan, John N. Waldron, Brian O’sullivan & Philippe Lambin. (2015) External validation of a prognostic CT-based radiomic signature in oropharyngeal squamous cell carcinoma. Acta Oncologica 54:9, pages 1423-1429.
Read now

Articles from other publishers (2)

R. Knecht, L. Bussmann, N. Möckelmann & B. B. Lörincz. (2016) Ist Radio(chemo)therapie wirklich der zukünftige Standard für die Behandlung von Oropharynxkarzinomen?Is (chemo)radiotherapy really the future standard in the treatment of oropharyngeal carcinoma?. HNO 64:4, pages 221-226.
Crossref
Balazs B. Lörincz, Nathan Jowett & Rainald Knecht. (2016) Decision management in transoral robotic surgery: Indications, individual patient selection, and role in the multidisciplinary treatment for head and neck cancer from a European perspective. Head & Neck 38:S1, pages E2190-E2196.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.